When should the terminally ill have access to relatively untested but potentially lifesaving drugs? What has the Supreme Court said about the right of medical treatment? J. Scott Ballenger, a partner with the Latham & Watkins law firm, makes the case for expanded access to experimental drugs among the terminally ill.
(See the full event: Should the Government Insert Itself between Dying Patients and Unproven Therapies?).